Richard Lindstrom is the founder of Surface Pharmaceuticals. Surface Pharmaceuticals has raised $25M in total funding. Latest round: Series A.
Richard Lindstrom, MD, is the Founder and Chairman of Surface Ophthalmics, a biopharmaceutical company focused on treating dry eye syndrome. He previously founded Minnesota Eye Consultants, P.A. and has over 40 years of experience in ophthalmology, serving as a researcher, teacher, inventor, writer, lecturer, physician, and surgeon.
Full founder directory · Investor directory · Company funding database · Fundraising library